Correlation Between Hard To and Hookipa Pharma

Can any of the company-specific risk be diversified away by investing in both Hard To and Hookipa Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hard To and Hookipa Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Hard to Treat and Hookipa Pharma, you can compare the effects of market volatilities on Hard To and Hookipa Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hard To with a short position of Hookipa Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hard To and Hookipa Pharma.

Diversification Opportunities for Hard To and Hookipa Pharma

0.0

Correlation Coefficient

Hard To  Hookipa Pharma

Pay attention - limited upside

The 3 months correlation between Hard and Hookipa is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Hard to Treat and Hookipa Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hookipa Pharma and Hard To is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hard to Treat are associated (or correlated) with Hookipa Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hookipa Pharma has no effect on the direction of Hard To i.e., Hard To and Hookipa Pharma go up and down completely randomly.

Pair Corralation between Hard To and Hookipa Pharma

If you would invest  0.00  in Hard to Treat on September 24, 2024 and sell it today you would earn a total of  0.00  from holding Hard to Treat or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	99.31%
Values	Daily Returns

Hard to Treat  vs.  Hookipa Pharma

Hard to Treat

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hard to Treat has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Hard To is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Hookipa Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hookipa Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Hard To and Hookipa Pharma

The main advantage of trading using opposite Hard To and Hookipa Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hard To position performs unexpectedly, Hookipa Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hookipa Pharma will offset losses from the drop in Hookipa Pharma's long position.

The idea behind Hard to Treat and Hookipa Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.